Cargando…

Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank

BACKGROUND: Biobanks are essential structures for scientific research. The RHINEVIT biobank is used to recruit biomaterials from rheumatology patients in outpatient care and to conduct clinical research studies (e.g., cohort studies) and basic research. RHINEVIT established Broad Consents (BC) to al...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Jutta G., Filla, Tim, Acar, Hasan, Bleck, Ellen, Kernder, Anna, Düsing, Christina, Vordenbäumen, Stefan, Schröder, Markus, Hansen, Ralf, Distler, Jörg H. W., Schneider, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321663/
https://www.ncbi.nlm.nih.gov/pubmed/37415767
http://dx.doi.org/10.3389/fmed.2023.1208006
_version_ 1785068661276409856
author Richter, Jutta G.
Filla, Tim
Acar, Hasan
Bleck, Ellen
Kernder, Anna
Düsing, Christina
Vordenbäumen, Stefan
Schröder, Markus
Hansen, Ralf
Distler, Jörg H. W.
Schneider, Matthias
author_facet Richter, Jutta G.
Filla, Tim
Acar, Hasan
Bleck, Ellen
Kernder, Anna
Düsing, Christina
Vordenbäumen, Stefan
Schröder, Markus
Hansen, Ralf
Distler, Jörg H. W.
Schneider, Matthias
author_sort Richter, Jutta G.
collection PubMed
description BACKGROUND: Biobanks are essential structures for scientific research. The RHINEVIT biobank is used to recruit biomaterials from rheumatology patients in outpatient care and to conduct clinical research studies (e.g., cohort studies) and basic research. RHINEVIT established Broad Consents (BC) to allow extensive and relevant usage of data and biospecimens without the need for specific project restrictions. For quality assurance, we compared the consent rate of individual items of the BC versions in patients with systemic lupus erythematosus (SLE) in the longitudinal study. METHODS: BCs were used for biomaterial donation. Informed consent data from RHINEVIT were analyzed. Due to the content restructuring of the BC items due to changes from the templates of the working group of the Medical Ethics Commissions in the Federal Republic of Germany and GDPR requirements, content mapping of the items was performed for the analysis. RESULTS: From September 2015 to March 2022, 291 SLE outpatients donated biomaterials. In 119 patients, the BC was renewed at least once in a subsequent biomaterial donation. Three biomaterial donations were obtained from 21 patients and four from six patients using the respective BC. However, one consent was later revoked. Consent to the BC topics showed consistently high rates of agreement (range 97.5%−100%), with only some patients disagreeing with individual topics. This remained stable over time (median 526 days [Q1 400, Q3 844]). None of the patients disagreed with a certain topic in two consecutive visits. CONCLUSION: Modifications to the BC did not result in any relevant changes in the approval rates for SLE patients. RHINEVIT's BC is successfully used for the quality-assured handling of excellently annotated biomaterial. The long-term use of these highly valuable biospecimens for unrestricted research, also in an international context, remains assured.
format Online
Article
Text
id pubmed-10321663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103216632023-07-06 Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank Richter, Jutta G. Filla, Tim Acar, Hasan Bleck, Ellen Kernder, Anna Düsing, Christina Vordenbäumen, Stefan Schröder, Markus Hansen, Ralf Distler, Jörg H. W. Schneider, Matthias Front Med (Lausanne) Medicine BACKGROUND: Biobanks are essential structures for scientific research. The RHINEVIT biobank is used to recruit biomaterials from rheumatology patients in outpatient care and to conduct clinical research studies (e.g., cohort studies) and basic research. RHINEVIT established Broad Consents (BC) to allow extensive and relevant usage of data and biospecimens without the need for specific project restrictions. For quality assurance, we compared the consent rate of individual items of the BC versions in patients with systemic lupus erythematosus (SLE) in the longitudinal study. METHODS: BCs were used for biomaterial donation. Informed consent data from RHINEVIT were analyzed. Due to the content restructuring of the BC items due to changes from the templates of the working group of the Medical Ethics Commissions in the Federal Republic of Germany and GDPR requirements, content mapping of the items was performed for the analysis. RESULTS: From September 2015 to March 2022, 291 SLE outpatients donated biomaterials. In 119 patients, the BC was renewed at least once in a subsequent biomaterial donation. Three biomaterial donations were obtained from 21 patients and four from six patients using the respective BC. However, one consent was later revoked. Consent to the BC topics showed consistently high rates of agreement (range 97.5%−100%), with only some patients disagreeing with individual topics. This remained stable over time (median 526 days [Q1 400, Q3 844]). None of the patients disagreed with a certain topic in two consecutive visits. CONCLUSION: Modifications to the BC did not result in any relevant changes in the approval rates for SLE patients. RHINEVIT's BC is successfully used for the quality-assured handling of excellently annotated biomaterial. The long-term use of these highly valuable biospecimens for unrestricted research, also in an international context, remains assured. Frontiers Media S.A. 2023-06-21 /pmc/articles/PMC10321663/ /pubmed/37415767 http://dx.doi.org/10.3389/fmed.2023.1208006 Text en Copyright © 2023 Richter, Filla, Acar, Bleck, Kernder, Düsing, Vordenbäumen, Schröder, Hansen, Distler and Schneider. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Richter, Jutta G.
Filla, Tim
Acar, Hasan
Bleck, Ellen
Kernder, Anna
Düsing, Christina
Vordenbäumen, Stefan
Schröder, Markus
Hansen, Ralf
Distler, Jörg H. W.
Schneider, Matthias
Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank
title Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank
title_full Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank
title_fullStr Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank
title_full_unstemmed Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank
title_short Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank
title_sort sustained agreement rates in the longitudinal assessment of lupus patients to a broad consent for personal data and specimen usage in the rhinevit biobank
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321663/
https://www.ncbi.nlm.nih.gov/pubmed/37415767
http://dx.doi.org/10.3389/fmed.2023.1208006
work_keys_str_mv AT richterjuttag sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT fillatim sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT acarhasan sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT bleckellen sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT kernderanna sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT dusingchristina sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT vordenbaumenstefan sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT schrodermarkus sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT hansenralf sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT distlerjorghw sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank
AT schneidermatthias sustainedagreementratesinthelongitudinalassessmentoflupuspatientstoabroadconsentforpersonaldataandspecimenusageintherhinevitbiobank